Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14300642 | 0.84 | LMNA (0.36) | LMNAMEN1KMT2AMAPTNPSR1 | |
| SCHEMBL3564833 | 0.84 | KIF11 (0.36) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL18464126 | 0.82 | HSP90AA1 (0.36) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL23665468 | 0.80 | LMNA (0.36) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL14493024 | 0.79 | CNR2 (0.33) | LMNAMAPTNPC1RAB9AMAPK1 | |
| SCHEMBL862821 | 0.79 | COMT (0.40) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL862603 | 0.77 | SENP1 (0.35) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL20806202 | 0.77 | COMT (0.39) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL13958188 | 0.77 | LMNA (0.42) | LMNAMEN1KMT2AMAPTTSHR | |
| SCHEMBL14495809 | 0.76 | CNR2 (0.32) | LMNAMAPTHSD17B10NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9179518-B2 | Light emissive device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-11-03 | — | — | US | disclosed |
| US-9136477-B2 | Light emissive device | CDT OXFORD LIMITED (GB) | 2015-09-15 | — | — | US | disclosed |
| US-9028715-B2 | Compositions and methods for manufacturing light-emissive devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-05-12 | — | — | US | disclosed |
| US-8981365-B2 | Organic light emissive device comprising a trilayer cathode including a layer comprising sodium fluoride | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-03-17 | — | — | US | disclosed |
| US-8878163-B2 | Light-emitting device and 9.9 biphenyl fluorene materials therefor | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2014-11-04 | — | — | US | disclosed |
| US-8648334-B2 | Organic light emissive device comprising a trilayer cathode | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2014-02-11 | — | — | US | disclosed |
| US-8440325-B2 | Electronic device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2013-05-14 | — | — | US | disclosed |
| US-8399605-B2 | Arylamine polymer | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2013-03-19 | — | — | US | disclosed |
| US-8389130-B2 | Opto-electrical polymers and devices | CDT OXFORD LIMITED (GB) | 2013-03-05 | — | — | US | disclosed |
| US-8294341-B2 | Organic electroluminescent device | CDT OXFORD LIMITED (GB) | 2012-10-23 | — | — | US | disclosed |
| US-20090227765-A1 | Monomer for making a crosslinked polymer | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2009-09-10 | — | — | US | disclosed |
| US-20090174314-A1 | Organic Light Emissive Device | CDT OXFORD LIMITED (GB) | 2009-07-09 | — | — | US | disclosed |
| US-20090167170-A1 | Polymer | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2009-07-02 | — | — | US | disclosed |
| US-20090091247-A1 | Organic Light-Emitting Device | CDT OXFORD LIMITED (GB) | 2009-04-09 | — | — | US | disclosed |
| US-20090072722-A1 | LIGHT EMISSIVE DEVICE | CTD OXFORD LIMITED (GB) | 2009-03-19 | — | — | US | disclosed |
| US-20090045740-A1 | Phosphorescent Organic Light Emissive Device | CDT OXFORD LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090026933-A1 | Organic Electroluminescent Device | CDT OXFORD LIMITED (GB) | 2009-01-29 | — | — | US | disclosed |
| US-20080315757-A1 | Electronic Device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2008-12-25 | — | — | US | disclosed |
| US-20080309229-A1 | Arylamine Polymer | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2008-12-18 | — | — | US | disclosed |
| US-20080197768-A1 | Light Emissive Device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227765-A1 | Monomer for making a crosslinked polymer | AR, RAD51, RAD1 | LMNA 1992/4885MEN1 803/4885KMT2A 1422/4885 |
| US-20090091247-A1 | Organic Light-Emitting Device | ARL1, RAD1, LAS1L | LMNA 2227/4885MEN1 577/4885KMT2A 2696/4885 |
| US-20080309229-A1 | Arylamine Polymer | NAT1, AR, AHR | LMNA 3266/4885MEN1 2021/4885KMT2A 822/4885 |
| US-20090167170-A1 | Polymer | AHR, PARG, PARN | LMNA 646/4885MEN1 3761/4885KMT2A 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.